期刊文献+

ICOS/GL50信号在T细胞依赖性体液免疫应答中的作用

Role of ICOS/GL50 Signal in T Cell Dependent Humoral Immune Responses
下载PDF
导出
摘要 研究ICOS/GL5 0信号在T细胞体外增殖、细胞因子分泌以及B细胞抗体分泌中的作用 ,进一步探讨该信号途径在机体体液免疫应答中的作用机制。采用3 H TdR检测GL5 0 L92 9转染细胞和特异性鼠抗人GL5 0单抗对T细胞体外增殖的作用 ;ELISA法检测GL5 0 L92 9转染细胞和抗人GL5 0单抗对T细胞分泌IL 2、IL 10以及ICOS L92 9转染细胞和特异性鼠抗人GL5 0单抗对PWM介导的B细胞分泌抗体的效应。结果提示GL5 0 L92 9转染细胞能够促进经抗CD3单抗活化的T细胞增值和分泌IL 10 ,而抗GL5 0单抗可以阻断这些效应。ICOS分子与B细胞上GL5 0分子的结合上调PWM介导的B细胞分泌抗体而抗GL5 0单抗则下调这一效应。这些表明 ,ICOS/GL5 To understand the role of ICOS/GL50 si gnal in T-cell dependent humoral immune responses by determining the signal function in T cell proliferation and cytokine secretion as well as B cell antibody production in vitro. GL50 and ICOS transfected L929 cells and the specific mouse-anti-human GL50 mAb were employed to study their impact on the proliferation of T cells in vitro by 3H-TdR measurements and on the cytokine secretion (IL-2 and IL-10) from anti-CD3 pretreated T cells and the antibody production from PWM-driven B cells by ELISA assay. Our results indicated that the stimulation GL50-L929 transfectants up regulated the vitro. Proliferat ion of preactivated T cells in absence of CD28 signaling, whose activation, however, furthered the proliferation enhancement, while the specific anti-GL50 mAb inhibited the T-cell proliferation. The treatment of GL50-L929 transfectants induced an enhanced production of IL-10, but not IL-2, from anti-CD3 experienced T cells while the IL-10 production was down regulated by anti-GL50 mAbs addition . The level of antibody secretion from PWM-driven B cells was upgraded in presence of ICOS-L929 stimulation. Anti-GL50 mAbs treatment, however, partly abrogated the up regulating effect. In conclusion, ICOS/CL50 signal played a key role in the secondary T cell dependent humoral immune responses.
出处 《现代免疫学》 CAS CSCD 北大核心 2004年第5期366-370,共5页 Current Immunology
基金 国家重点基础研究发展项目 ( 2 0 0 1CB5 10 0 0 3 ) 国防科工委基金资助项目 (委技函 2 0 0 3 44号 )
关键词 ICOS GL50 共刺激分子 体液免疫 ICOS GL50 costimulatory molecule humoral immune responses
  • 相关文献

参考文献9

  • 1[1]Chambers CA. The expanding world of costimulation:the two-signal model revisited[J]. Trends Immunol,2001,22:217.
  • 2[2]Lenschow DJ,Walunas TL, Blueestone JA,et al. CD28/B7 system of T cell costimulation[J]. Annu Rev Immunol,1996,14:233.
  • 3[3]Shahinian A,Pfeffer K,Lee KP,et al. Differential T cell costimulatory requirements in CD28-deficient mice[J]. Science,1993,261:609.
  • 4[4]Ling V,Wu PW,Finnerty HF,et al. Differential expression of inducible costimulator-ligand splice variants:lymphoid regulation of mouse GL50-B and human GL50 molecules[J]. Immunology,2001,166:7300.
  • 5[5]Guo Y,Wu Y,Zhao M,et al. Mutational analysis and an alternatively spliced product of B7 defined its CD28/CTLA-4-binding site on immunoglubolin G-like domain[J]. J Exp Med,1995,181:1345.
  • 6[6]Hutloff A,Dittrich AM,Beier KC,et al. ICOS is an inducible T-cell costimulator structurally and functionally related to CD28[J]. Nature,1999,397:263.
  • 7[7]Yoshinaga SK,Whoriskey JS,Khare SD,et al. T-cell costimulation through B7RP-1 and ICOS[J]. Nature,1999,402:827.
  • 8[8]Siew CW,Edwin OH,Chee HN,et al. Impaired germinal center formation and recall T cell-dependent immune responses in mice lacking the costimulatory ligand B7-H2[J]. Blood,prepublished online. DOI 10.1182/blood-2002-08-2416.
  • 9[9]Riley JL,Blair PJ,Musser JT,et al. ICOS costimulation requires IL-2 and can be prevented by CTLA-4 engagement[J]. J Immunol,2001,166:4943.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部